MED
Income statement / Annual
Last year (2024), Medifast, Inc.'s total revenue was $602.46 M,
a decrease of 43.80% from the previous year.
In 2024, Medifast, Inc.'s net income was $2.09 M.
See Medifast, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$602.46 M |
$1.07 B |
$1.60 B |
$1.53 B |
$934.84 M |
$713.67 M |
$501.00 M |
$301.56 M |
$274.53 M |
$272.77 M |
| Cost of Revenue |
$157.84 M
|
$296.20 M
|
$458.16 M
|
$398.49 M
|
$237.03 M
|
$176.81 M
|
$121.10 M
|
$73.75 M
|
$68.87 M
|
$71.46 M
|
| Gross Profit |
$444.62 M
|
$775.85 M
|
$1.14 B
|
$1.13 B
|
$697.82 M
|
$536.86 M
|
$379.90 M
|
$227.81 M
|
$205.66 M
|
$201.32 M
|
| Gross Profit Ratio |
0.74
|
0.72
|
0.71
|
0.74
|
0.75
|
0.75
|
0.76
|
0.76
|
0.75
|
0.74
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$441.75 M
|
$649.45 M
|
$955.61 M
|
$911.36 M
|
$563.66 M
|
$445.82 M
|
$310.84 M
|
$188.18 M
|
$178.81 M
|
$172.63 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$441.75 M
|
$649.45 M
|
$955.61 M
|
$911.36 M
|
$563.66 M
|
$445.82 M
|
$310.84 M
|
$188.18 M
|
$178.81 M
|
$172.63 M
|
| Cost And Expenses |
$599.59 M
|
$945.65 M
|
$1.41 B
|
$1.31 B
|
$800.68 M
|
$622.63 M
|
$431.94 M
|
$261.93 M
|
$247.68 M
|
$244.09 M
|
| Interest Income |
$4.80 M
|
$2.49 M
|
$0.00
|
$0.00
|
$246.00 K
|
$1.30 M
|
$1.31 M
|
$558.00 K
|
$283.00 K
|
$661.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$701.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$12.71 M
|
$13.11 M
|
$10.98 M
|
$6.81 M
|
$4.32 M
|
$4.62 M
|
$4.44 M
|
$4.21 M
|
$5.41 M
|
$7.12 M
|
| EBITDA |
$15.59 M |
$139.51 M |
$195.74 M |
$223.05 M |
$138.48 M |
$95.66 M |
$73.50 M |
$43.84 M |
$32.26 M |
$35.80 M |
| EBITDA Ratio |
0.03
|
0.13
|
0.12
|
0.15
|
0.15
|
0.13
|
0.15
|
0.15
|
0.12
|
0.13
|
| Operating Income Ratio |
0
|
0.12
|
0.12
|
0.14
|
0.14
|
0.13
|
0.14
|
0.13
|
0.1
|
0.11
|
| Total Other Income/Expenses Net |
$909.00 K
|
$2.40 M
|
-$747.00 K
|
-$112.00 K
|
$106.00 K
|
$1.32 M
|
$1.49 M
|
$694.00 K
|
$263.00 K
|
$987.00 K
|
| Income Before Tax |
$3.79 M
|
$128.80 M
|
$184.06 M
|
$216.13 M
|
$134.27 M
|
$92.36 M
|
$70.55 M
|
$40.33 M
|
$27.12 M
|
$29.67 M
|
| Income Before Tax Ratio |
0.01
|
0.12
|
0.12
|
0.14
|
0.14
|
0.13
|
0.14
|
0.13
|
0.1
|
0.11
|
| Income Tax Expense |
$1.70 M
|
$29.38 M
|
$40.49 M
|
$52.10 M
|
$31.41 M
|
$14.45 M
|
$14.76 M
|
$12.61 M
|
$9.29 M
|
$10.10 M
|
| Net Income |
$2.09 M
|
$99.42 M
|
$143.57 M
|
$164.03 M
|
$102.86 M
|
$77.92 M
|
$55.79 M
|
$27.72 M
|
$17.84 M
|
$20.06 M
|
| Net Income Ratio |
0
|
0.09
|
0.09
|
0.11
|
0.11
|
0.11
|
0.11
|
0.09
|
0.06
|
0.07
|
| EPS |
0.19 |
9.1 |
12.82 |
14.01 |
8.74 |
6.62 |
4.67 |
2.32 |
1.51 |
1.68 |
| EPS Diluted |
0.19 |
9.1 |
12.73 |
13.89 |
8.68 |
6.43 |
4.62 |
2.29 |
1.49 |
1.66 |
| Weighted Average Shares Out |
$10.93 M
|
$10.88 M
|
$11.20 M
|
$11.71 M
|
$11.77 M
|
$11.77 M
|
$11.95 M
|
$11.92 M
|
$11.84 M
|
$11.96 M
|
| Weighted Average Shares Out Diluted |
$10.96 M
|
$10.92 M
|
$11.28 M
|
$11.81 M
|
$11.85 M
|
$12.12 M
|
$12.08 M
|
$12.09 M
|
$11.95 M
|
$12.07 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
